SynthesisAmerican journal of cardiovascular drugs : drugs, devices, and other interventions2024

Cardiovascular Benefits of GLP-1 Receptor Agonists in Patients Living with Obesity or Overweight: A Meta-analysis of Randomized Controlled Trials.

Gustavo de Oliveira Almeida et al.PubMed ↗Publisher ↗

No numbers read from the abstract.